期刊文献+

应用水痘-带状疱疹病毒报告细胞系筛选抗病毒药物的研究 被引量:2

Reporter cell line-based screening for anti-varicella-zoster virus compounds
原文传递
导出
摘要 目的应用构建的水痘.带状疱疹病毒(VZV)报告细胞系MVgG建立一种筛选抗VZV药物的新方法。方法将VZV疫苗株(vOka)的无细胞病毒液(CFV)直接感染MV9G细胞2h后移除(CFV直接感染法),或将感染vOka株的Mewo细胞(含带细胞病毒,CAV)与MV9G细胞共培养48h(CAV共培养法),以激发MV9G细胞表达报告基因萤火虫荧光素酶。在培养基中加入肝素、磷酸甘露糖(M-6-P)、阿昔洛韦(ACV)、白藜芦醇、roscovitine等抗病毒药物,通过比较加药前后MV9G细胞荧光素酶活性变化来分析药物对VzV的作用。结果抗病毒药物各浓度组不同程度地抑制CFV直接感染和/或CAV共培养激发的MV9G细胞荧光素酶活性,荧光素酶活性的降低与平行对照组中病毒蚀斑数的降低一致。抗病毒药物中肝素、M-6-P和roscovitine2.5μmol/L组抑制CFV激发荧光素酶的作用强于抑制CAV激发荧光素酶的作用,而ACV和白藜芦醇抑制CAV激发荧光素酶的作用强于抑制CFV激发荧光素酶的作用。ACV抗药株Kanno和rOkaYSR的CAV与MVgG细胞共培养均激发其强表达荧光素酶,但ACV抑制抗药株激发荧光素酶50%时浓度(IC50)显著高于抑制敏感株pOka和CaGu的IC50。结论CFV直接感染法和CAV共培养法分别有助于筛选针对VZV感染早期和后期的药物,利用MV9G细胞建立的报告细胞法可为抗VzV药物筛选和作用机制研究提供一种简便、快速、敏感和高通量的新方法。 Objective To establish a novel method to screen for anti-varicella-zoster virus (VZV) compounds with our previously generated reporter cell line for VZV, MV9G. Methods MV9G cells were drectly infected with cell-free virus of Oka vaccine strain (vOka) for 2 hours( CFV direct-infection) or cocultured with vOka-infected MeWo cells containing cell-associated virus for 48 hours ( CA co-culture) to promote expression of the reporter gene firefly luciferase. Antiviral compounds including heparin, mannose- 6-phosphate( M-6-P), acyclovir( ACV), resveratrol and roscovitine were added in the medium before or after the virus infection. Inhibitory effects( IC50 ) of the antiviral compounds were analyzed by comparing firefly luciferase activities of MV9G cells in the presence of antiviral compounds with those in the absence. Results Antiviral compounds inhibited luciferase activities of MVgG cells activated by CFV direct-infection and/or CAV co-culture in different levels. The reductions of luciferase activities statistically correlated with those of viral foci shown by immunostaining with a monoclonal antibody against VZV immediate early 62 antigens (IE62) in controls. Among these compounds, heparin, M-6-P, and 2.5μmol/L of roscovitine inhibited CFV-activated more strongly than CAV-activated luciferase activities, whereas ACV and resveratrol inhibited CAV-activated more strongly than CFV-activated luciferase activities. Cell-associated ACV-resistant strains, Kanno and rOka YSR, activated luciferase activities of MVgG cells, too. However, the inhibitory concentrations ( IC50 ) of ACV to the ACV-resistant strains were much higher than those to the ACV-sensitive strains, pOka and CaGu. Conclusion The CFV direct-infection and CAV co-culture assays were useful to screen for antiviral compounds targeting the early and late phases of VZV infection, respectively. The VZV reporter cell-based assays may provide a simple, rapid, sensitive, and high-throughput method to screen for anti-VZV compounds.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2011年第8期745-750,共6页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(30671884,30840070) 福建省高校新世纪优秀人才支持计划资助项目(闽教科2007年20号) 厦门市卫生局医学科研基金资助项目(WSK0618)
关键词 水痘-带状疱疹病毒 报告细胞系 磷酸甘露糖 白黎芦醇 ROSCOVITINE Varicella-zoster virus Reporter cell line Mannose-6-phosphate Resveratrol Rosco- vitine
  • 相关文献

参考文献9

  • 1Gilbert C, Bestman-Smith J, Boivin G. Resistance of herpesvirus- es to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat, 2002, 5(2): 88-114.
  • 2De Clercq E. Antiviral drug discovery and development: where chemistry meets with biomedicine. Antiviral Res, 2005, 67 ( 2 ) : 56-75.
  • 3Wang GQ, Suzutani T, Yamamoto Y, et al. Generation of a re- porter cell line for detection of infectious varicella-zoster virus and its application to antiviml studies. Antimicrob Agents Chemother, 2006, 50(9) : 3142-3145.
  • 4王官清,井上直树,野沢直树.水痘-带状疱疹病毒报告细胞系的构建及特性分析[J].中华微生物学和免疫学杂志,2008,28(3):212-216. 被引量:4
  • 5De Clercq E. 2001 ASPET Otto Krayer Award Lecture. Molecular targets for antiviral agents. J Phannacol Exp Ther, 2001, 297(1) : 1-10.
  • 6Shiraki K, Ochiai H, Namazue J, et al. Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus. Antiviral Res, 1992, 18(2) : 209-214.
  • 7Zhu Z, Gershon MD, Ambron R, et al. Infection of cells by vari- eella zoster virus : inhibition of viral entry by mannose 6-phosphate and heparin. Proc Natl Acad Sci USA, 1995,92(8) :3546-3550.
  • 8Docherty JJ, Sweet TJ, Bailey E, et al. Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res, 2006, 72(3) : 171-177.
  • 9Taylor SL, Kinchington PR, Brooks A, et al. Roscovitine, a cyc- lin-dependent kinase inhibitor, prevents replication of varicella- zoster virus. J Virol, 2004, 78(6): 2853-2862.

二级参考文献11

  • 1王官清,井上直樹,野沢直樹.水痘-带状疱疹病毒基因启动子分析[J].中华微生物学和免疫学杂志,2007,27(5):400-404. 被引量:5
  • 2Gilbert CJ, Bestman-Smith, Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisrns. Drug Resist Updat, 2002, 5 (2) : 88-114.
  • 3Inoue N, Winter J, Lal RB, et al. Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line. J Virol, 2003, 77 (14): 8147-8152.
  • 4Grose C, Brunell PA. Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 320C. Infect Immun, 1978, 19(1) : 199-203.
  • 5Zerboni L, Sommer M, Ware CF, et al. Varicella-zoster virus infection of a human CD4-positive T-cell line. Virology, 2000, 270 (2) : 278-285.
  • 6Quinlivan M, Breuer J. Molecular studies of Varicella-zoster virus. Rev Med Virol, 2006, 16(4) : 225-250.
  • 7Ruyeehan WT, Peng H, Yang M, et al. Cellular factors and IE62 activation of VZV promoters. J Med Virol, 2003, 70 ( suppl 1 ) : S90-S94.
  • 8Rahaus M, Desloges N, Yang M, et al. Transcription factor USF, expressed during the entire phase of varicella-zoster virus infection, interacts physically with the major viral transactivator IE62 and plays a significant role in virus replication. J Gen Virel, 2003, 84 (pt 11) : 2957-2967.
  • 9Zhu Z, Gershon MD, Ambron R, et al. Infection of cells by varicelia zoster virus : inhibition of viral entry by mannose 6-phosphate and heparin. Proc Natl Acad Sci USA, 1995, 92 (8): 3546- 3550.
  • 10Li Q, All MA, Cohen JI. Insulin degrading enzyme is a cellular receptor mediating varieella-zoster virus infection and cell-to-cell spread. Cell, 2006, 127 (2) : 305-316.

共引文献3

同被引文献13

  • 1Cohen JI, Straus SE, Arvin AM. Varicella-zoster virus replica- tion, pathogenesis and management. Knipe DM, Howley PM. Fields Virology, vol II, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2007, 2774-2818.
  • 2Gilbert C, Bestman-Smith J, Boivin G. Resistance of herpesvirus- es to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat, 2002, 5(2) : 88-114.
  • 3Mukhtar M, Arshad M, Ahmad M, et al. Antiviral potentials of medicinal plants. Virus Res, 2008, 131(2) : 111-120.
  • 4Docherty JJ, Fu MM, Stiffler BS, et al. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res, 1999, 43 (3): 145-155.
  • 5Docherty JJ, Sweet TJ, Bailey E, et al. Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res, 2006, 72(3) : 171-177.
  • 6Wang GQ, Suzutani T, Yamamoto Y, et al. Generation of a re- porter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies. Antimicrob Agents Chemother, 2006, 50(9): 3142-3145.
  • 7Zhu Z, Gershon MD, Ambron R, et al. Infection of cells by vari- celia zoster virus : inhibition of viral entry by mannose 6-phosphate and heparin. Proc Natl Acad Sci USA, 1995, 92 (8): 3546- 3550.
  • 8Docherty JJ, Smith JS, Fu MM, et al. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice. Antiviral Res, 2004, 61 ( 1 ) : 19-26.
  • 9Docherty JJ, Fu MM, Hah JM, et al. Effect of resveratrol on her- pes simplex virus vaginal infection in the mouse. Antiviral Res, 2005, 67(3) : 155-162.
  • 10Faith SA, Sweet TJ, Bailey E, et al. Resveratrol suppresses nu- clear factor-kappaB in herpes simplex virus infected ceils. Antivi- ral Res, 2006, 72(3) : 242-251.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部